1
Enquiry period
with 05.06.2024 11:11
to 17.06.2024 11:00
2
Bidding period
with 17.06.2024 11:00
to 08.07.2024 14:00
9 days left
3
Auction

4
Evaluation
5
Bids have been evaluated
Status Active
Estimated value without VAT 5 794 767,71 MDL
Period of clarifications: 5 Jun 2024, 11:11 - 17 Jun 2024, 11:00
Submission of proposals: 17 Jun 2024, 11:00 - 8 Jul 2024, 14:00
Auction start date: will not be used

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Submit offer
Golimumab
45
mg/0.45ml
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
Date modified
11 Jun 2024, 16:59
Estimated value (without VAT)
5 794 767,71 MDL
Achizitii.md ID
21233681
Type of procedure
Open tender
Award criteria
The lowest price
Delivery address
MD-2009, MOLDOVA, mun.Chişinău, mun.Chişinău, IMSP Institutul Mamei și Copilului
Contract period
1 Jan 2025 02:00 - 31 Dec 2025 02:00
List of positions
1)
Title
Golimumab 45 mg/0.45ml CPV: 33600000-6 - Pharmaceutical products
Quantity: 372.0
Unit of measurement: Bucata
Documents of the procurement procedure
contract subsecvent
Bidding Documents
contract subsecvent
5.06.24 11:11
Anunt de participare final.signed
Bidding Documents
Anunt de participare
5.06.24 11:11
Propunerea financiară
Technical Specifications
Propunerea financiară
5.06.24 11:11
ACORD_-_cadru_documentația
Bidding Documents
ACORD_-_cadru_documentația
5.06.24 11:11
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
5.06.24 11:11
DUAE Model
Bidding Documents
DUAE Model
11.06.24 16:59
contract subsecvent 11.06.2024
Bidding Documents
contract subsecvent 11.06.2024
11.06.24 16:59
Propunerea tehnică
Technical Specifications
Propunerea tehnică
11.06.24 16:59
Unfortunately, questions can be asked only during the "Active" period.
Clarifications